Search

everythinglearnresearchcommunity

for

Search:↓

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Finasteride reduces hair growth better, but spironolactone has more side effects.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Flutamide reduces hair growth better but has more side effects.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Using neurohormones to control keratin can lead to new skin disease treatments.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Birth control pills can help reduce mild to moderate acne in women.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.